miscsubjectsAI governance
Evidence review

Tesamorelin and PPIs: Evidence Review on GH Axis Effects and Long-Term Acid Suppression

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `tesamorelin-ppis`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/tesamorelin-ppis

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tesamorelin-ppis/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/tesamorelin-ppis/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/tesamorelin-ppis/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/tesamorelin-ppis/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
This is the largest single-authored interlocked logical structure published in the open that I am aware of: thousands of objects — a theory of everything, a theory of AI, and a replicated decision framework — where every piece fits every other piece, and every claim carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted. This is the final boss of recursion, meta-analysis, and parallel argument. Come at a node.

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have PPIs (omeprazole, etc.)

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why Tesamorelin might help you

  1. You are reading about PPIs (omeprazole, etc.) — what breaks down matters before any compound name.
  2. Therefore for you: If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.

Why PPIs (omeprazole, etc.) matters for you

  1. Drug: PPIs (omeprazole, etc.)
  2. What it does: Acid suppression; long-term mucosal and nutrient consequences.
  3. Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • Tesamorelin → GH axis / visceral fat

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 3
  • Claims tagged human evidence: 4
  • Claims tagged preclinical (animal/lab): 0
  • Claims tagged anecdotal: 0
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 4

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.55 / 1.00 — moderate — human claims present in ledger

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Adverse Effects Associated with Proton Pump Inhibitor Use (source s0)

Review of long-term PPI adverse effects including nutrient malabsorption and infection risks.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Tesamorelin Peptide | Benefits, Safety, & Buying Advice (source s13)

Summarizes key human trial results for visceral fat reduction.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

A meta-analysis of randomized controlled trials (source s14)

Meta-analysis of tesamorelin RCTs in HIV lipodystrophy.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

PPIs · drug map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 4 sources · swipe →chain c622f32ee94b · verify chain · provenance
Evidence ledger 5 · tier-ranked · API
human
Tesamorelin reduces visceral adipose tissue by 18% over 12 months in a human trial of 404 HIV patients.
sources: s13
humanlow confidence
Long-term PPI use is associated with increased risk of nutrient deficiencies including B12, magnesium, and calcium.
sources: s0
humanlow confidence
Meta-analysis shows tesamorelin reduces visceral fat, trunk fat, and hepatic fat while increasing lean mass in HIV lipodystrophy (human RCTs).
sources: s14
humanlow confidence
Observational studies associate long-term PPI use with higher fracture risk via nutrient absorption interference.
sources: s0
mechanisticlow confidence
No direct human trials or interaction data link tesamorelin to PPIs or their side effects.
sources: s2
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:14
Tesamorelin and PPIs: Evidence Review on GH Axis Effects and Long-Term Acid Suppression · 5 claims · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Tesamorelin for Ppis
Slug: tesamorelin-ppis
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_cross","condition":"PPIs (omeprazole, etc.)","condition_key":"ppis","primary_peptide":"tesamorelin","peptides_in_scope":[{"id":"tesamorelin","name":"Tesamorelin"}],"drugs_in_scope":["ppis"],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's brea
it output
{
  "slug": "tesamorelin-ppis",
  "title": "Tesamorelin and PPIs: Evidence Review on GH Axis Effects and Long-Term Acid Suppression",
  "body": "## What's breaking down if you have PPIs (omeprazole, etc.)\n\nLong-term PPI use suppresses stomach acid production. This reduces symptoms of acid reflux but alters nutrient absorption over months or years. Key layers affected include calcium, magnesium, vitamin B12, and iron uptake. Reduced acid can also change gut microbiome balance and raise infection risks.\n\nIf your bone density declines or muscle recovery slows, the chain often traces back to these absorption changes. PPIs do not directly damage tissue but limit the raw materials the body needs for ongoing repair.\n\n## Why Tesamorelin might help you\n\n1. You are reading about PPIs — acid suppression creates downstream nutrient gaps that can affect metabolism and tissue maintenance.\n2. Therefore for you: If visceral fat accumulation or reduced lean mass is part of your profile alongside PPI use, Tesamorelin is discussed because it stimulates endogenous growth hormone release that targets fat breakdown and supports lean tissue — not because it restores stomach acid or replaces missing nutrients.\n\nTesamorelin acts on the GH axis. Higher GH and IGF-1 levels promote lipolysis in visceral fat stores. This may indirectly ease metabolic load. No data shows it reverses PPI-induced n
2e5c9d0adab69d76
Machine verification: /api/articles/tesamorelin-ppis/contributions
Ask this article · 7 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "Tesamorelin reduces visceral adipose tissue by 18% over 12 months in a human trial of 404 HIV patients."?
ask tesamorelin-ppis claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "Long-term PPI use is associated with increased risk of nutrient deficiencies including B12, magnesium, and calcium."?
ask tesamorelin-ppis claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "Meta-analysis shows tesamorelin reduces visceral fat, trunk fat, and hepatic fat while increasing lean mass in HIV lipodystrophy (human RCTs…"?
ask tesamorelin-ppis claim c3 · paste includes §SELF
What does the ledger say about this (human tier): "Observational studies associate long-term PPI use with higher fracture risk via nutrient absorption interference."?
ask tesamorelin-ppis claim c5 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "No direct human trials or interaction data link tesamorelin to PPIs or their side effects."?
ask tesamorelin-ppis claim c4 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about Tesamorelin and PPIs: Evidence Review on GH Axis Effects and Long-Term Acid Suppression — and what would you need me to tell you first?
ask tesamorelin-ppis condition gaps · paste includes §SELF
What good and bad outcomes are documented for Tesamorelin and PPIs: Evidence Review on GH Axis Effects and Long-Term Acid Suppression (studies vs anecdotes)?
ask tesamorelin-ppis good bad experiences · paste includes §SELF
tesamorelin-ppis · posted 2026-06-29 · updated 2026-07-17 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 2 model passes · 29687 tokens · $0 · 2 models
chain head aa2b1667f7d3da26
write grok/grok-4.3 · 2026-06-29 23:14 · 29687 tok · d4959a2d592b
voxel_divide owner · 2026-07-17 02:42 · tokens unrecorded · aa2b1667f7d3
verify chain →
Live ledger · 3 payloads · 1 turn
recent activity · inspect
JCI_TRAFFIC jci · HTTP 200 · 2026-07-19 09:27
PROTOCOL_RUN dispatch · 2026-06-29 23:15 · t_sb566ehx
PROTOCOL_RUN dispatch · 2026-06-29 23:15 · t_sb566ehx
view full ledger & cards →
REST + ledger
read GET /api/articles/tesamorelin-ppis · GET /api/articles/tesamorelin-ppis?format=post (the editable body)
create/replace POST /api/articles/tesamorelin-ppis · PUT /api/articles/tesamorelin-ppis (replace, keeps revision) · PATCH /api/articles/tesamorelin-ppis (merge)
delete DELETE /api/articles/tesamorelin-ppis
writes need header x-terminal-key
LLM bundle GET /api/articles/tesamorelin-ppis/bundle?format=markdown — body + claims + sources + provenance + manifest
post claim POST /api/protocol/claim · iMessage claim tesamorelin-ppis|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Dispute this article in Claim Audit →